# IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD

> **NCT02066051** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 8 (actual)

## Conditions studied

- GVHD
- Ocular Rosacea
- Dry Eye Syndrome

## Interventions

- **DEVICE:** IPL
- **PROCEDURE:** Meibomian Gland Expression

## Key facts

- **NCT ID:** NCT02066051
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2015-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02066051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02066051, "IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02066051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*